Replies to post #114530 on Biotech Values

[10nisman]

All told, potential competition from this product is far down on my list of concerns as a MNTA investor.

Dew - other than one-off chances of a tL approval or the FDA changing their mind and requiring mC to do trials, what are your biggest concerns as a MNTA investor at the current market capitalization of ~$420 million (net of cash, A/R and NOLs)?

10nis